Abbott Laboratories
ABT130.620USD
+0.120+0.09%
收盘 04/30, 16:00（美东）报价延迟15分钟
226.19B总市值
16.88市盈率 TTM
关于 Abbott Laboratories 公司
雅培实验室是一家全球医疗保健公司。该公司从事多种多样的医疗保健产品的发现、开发、制造和销售。该公司通过四个部门运营：成熟医药产品部门、诊断产品部门、营养产品部门和医疗器械部门。成熟医药产品部门从事多种品牌仿制药产品的国际销售。诊断产品部门从事血库、医院、商业实验室和替代护理检测站的诊断系统和测试的全球销售。营养产品部门从事多种成人和儿童营养产品的全球销售。医疗器械部门包括节律管理、电生理学、心力衰竭、血管、结构性心脏、神经调节和糖尿病护理产品的全球销售。
公司简介
公司代码ABT
公司名称Abbott Laboratories
上市日期Mar 01, 1937
成立日期1900
CEOMr. Robert B. Ford
员工数量114000
证券类型Ordinary Share
年结日Mar 01
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NYSE Consolidated
国家United States of America
邮编60064-3500
电话12246676100
网址https://www.abbott.com
公司代码ABT
上市日期Mar 01, 1937
成立日期1900
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.88K
-1.63%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
56.91K
+44.72%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
36.66K
+4.67%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.88K
-1.63%
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Diabetes Care
6.80B
16.22%
Core Laboratory
5.24B
12.48%
Adult Nutritionals
4.39B
10.46%
Pediatric Nutritionals
4.02B
9.59%
Key Emerging Markets
3.86B
9.20%
Other
17.64B
42.05%
地区USD
名称
营收
占比
United States
16.32B
38.91%
All other Countries
14.85B
35.39%
Germany
2.54B
6.05%
China
2.11B
5.04%
India
1.82B
4.33%
Other
4.31B
10.28%
业务
地区
业务USD
名称
营收
占比
Diabetes Care
6.80B
16.22%
Core Laboratory
5.24B
12.48%
Adult Nutritionals
4.39B
10.46%
Pediatric Nutritionals
4.02B
9.59%
Key Emerging Markets
3.86B
9.20%
Other
17.64B
42.05%
股东统计
更新时间: 2月9日 周日
更新时间: 2月9日 周日
持股股东
股东类型
持股股东
股东统计
占比
The Vanguard Group, Inc.
9.68%
BlackRock Institutional Trust Company, N.A.
5.02%
State Street Global Advisors (US)
4.45%
Capital International Investors
3.92%
Capital Research Global Investors
3.12%
Other
73.81%
持股股东
股东统计
占比
The Vanguard Group, Inc.
9.68%
BlackRock Institutional Trust Company, N.A.
5.02%
State Street Global Advisors (US)
4.45%
Capital International Investors
3.92%
Capital Research Global Investors
3.12%
Other
73.81%
股东类型
股东统计
占比
Investment Advisor
35.63%
Investment Advisor/Hedge Fund
32.73%
Research Firm
3.15%
Pension Fund
2.28%
Bank and Trust
2.13%
Sovereign Wealth Fund
1.31%
Insurance Company
0.99%
Hedge Fund
0.89%
Individual Investor
0.48%
Other
20.41%
机构持股
更新时间: 1月19日 周日
更新时间: 1月19日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q1
4527
1.39B
80.29%
+21.54M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.36B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.03M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.35B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.35B
77.60%
-13.55M
2023Q1
4281
1.35B
77.46%
-8.61M
2022Q4
4258
1.34B
76.84%
-15.37M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
167.89M
9.68%
+762.54K
+0.46%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
87.07M
5.02%
+811.85K
+0.94%
Dec 31, 2024
State Street Global Advisors (US)
77.17M
4.45%
+447.25K
+0.58%
Dec 31, 2024
Capital International Investors
67.97M
3.92%
+2.23M
+3.39%
Dec 31, 2024
Capital Research Global Investors
54.10M
3.12%
+795.07K
+1.49%
Dec 31, 2024
Geode Capital Management, L.L.C.
35.67M
2.06%
+765.64K
+2.19%
Dec 31, 2024
Wellington Management Company, LLP
26.39M
1.52%
+581.33K
+2.25%
Dec 31, 2024
JP Morgan Asset Management
25.13M
1.45%
+5.11M
+25.51%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
20.98M
1.21%
+626.72K
+3.08%
Dec 31, 2024
Wells Fargo Advisors
15.25M
0.88%
-105.40K
-0.69%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月5日 周六
更新时间: 4月5日 周六
机构名称
占比
iShares U.S. Medical Devices ETF
17.41%
Invesco Pharmaceuticals ETF
5.78%
Goldman Sachs Future Health Care Equity ETF
5.19%
NYLI Healthy Hearts ETF
4.78%
Polen Capital Global Growth ETF
4.77%
AdvisorShares Focused Equity ETF
4.63%
Proshares Ultra Health Care
4.32%
Health Care Select Sector SPDR Fund
4.24%
iShares U.S. Healthcare ETF
4.15%
Fidelity MSCI Health Care Index ETF
3.85%
查看更多
iShares U.S. Medical Devices ETF
占比17.41%
Invesco Pharmaceuticals ETF
占比5.78%
Goldman Sachs Future Health Care Equity ETF
占比5.19%
NYLI Healthy Hearts ETF
占比4.78%
Polen Capital Global Growth ETF
占比4.77%
AdvisorShares Focused Equity ETF
占比4.63%
Proshares Ultra Health Care
占比4.32%
Health Care Select Sector SPDR Fund
占比4.24%
iShares U.S. Healthcare ETF
占比4.15%
Fidelity MSCI Health Care Index ETF
占比3.85%
分红派息
近5年累计派现
16.46B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据